Education
About Us
Working with TipRanks
Follow Us
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB
TRIB Stock Chart & Stats
$1.00
-$0.09(-10.05%)
At close: 4:00 PM EST
$1.00
-$0.09(-10.05%)
Day’s Range― - ―
52-Week Range$0.48 - $3.44
Previous CloseN/A
Volume141.89K
Average Volume (3M)136.14K
Market Cap
$18.05M
Enterprise Value$102.30M
Total Cash (Recent Filing)$4.07M
Total Debt (Recent Filing)$107.97M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
Dec 11, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 05, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding18,632,019
10 Day Avg. Volume159,092
30 Day Avg. Volume136,139
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)-2.25
Price to Sales (P/S)1.28
P/FCF Ratio-5.54
Enterprise Value/Market Cap5.67
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit5.85
Enterprise Value/Ebitda-5.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Trinity Biotech News
TRIB FAQ
What was Trinity Biotech Plc’s price range in the past 12 months?
Trinity Biotech Plc lowest stock price was $0.48 and its highest was $3.44 in the past 12 months.
What is Trinity Biotech Plc’s market cap?
Trinity Biotech Plc’s market cap is $18.05M.
When is Trinity Biotech Plc’s upcoming earnings report date?
Trinity Biotech Plc’s upcoming earnings report date is Dec 11, 2025 which is in 7 days.
How were Trinity Biotech Plc’s earnings last quarter?
Currently, no data Available
Is Trinity Biotech Plc overvalued?
According to Wall Street analysts Trinity Biotech Plc’s price is currently Overvalued.
Does Trinity Biotech Plc pay dividends?
Trinity Biotech Plc pays a Annually dividend of $1.1 which represents an annual dividend yield of N/A. See more information on Trinity Biotech Plc dividends here
What is Trinity Biotech Plc’s EPS estimate?
Trinity Biotech Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Trinity Biotech Plc have?
Trinity Biotech Plc has 18,632,019 shares outstanding.
What happened to Trinity Biotech Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Trinity Biotech Plc?
Currently, no hedge funds are holding shares in TRIB
Company Description
Trinity Biotech Plc
Trinity Biotech is a global leader in the field of diagnostics, specializing in the development, manufacture, and marketing of diagnostic products for the healthcare market. The company operates primarily in the sectors of clinical laboratory diagnostics and point-of-care testing, offering a wide range of products that include immunoassays, molecular diagnostics, and other laboratory instruments. Trinity Biotech's core products are utilized for the diagnosis of infectious diseases, diabetes, and other chronic conditions, thereby supporting healthcare providers in delivering effective patient care.
Technical Analysis
Check-Cap
―
Precipio
―
BioNano Genomics
―
Intelligent Bio Solutions
―
bioAffinity Technologies, Inc.
―
Ownership Overview
―
Insiders
0.09% Mutual Funds
12.64% Other Institutional Investors
87.27% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---